A detailed history of Caption Management, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Caption Management, LLC holds 297,500 shares of ADMA stock, worth $4.63 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
297,500
Previous 347,600 14.41%
Holding current value
$4.63 Million
Previous $6.33 Million 31.09%
% of portfolio
0.04%
Previous 0.08%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$14.66 - $19.91 $1.28 Million - $1.73 Million
87,000 Added 80.56%
195,000 $2.86 Million
Q2 2025

Aug 14, 2025

BUY
$17.6 - $24.51 $1.9 Million - $2.65 Million
108,000 New
108,000 $1.97 Million

Others Institutions Holding ADMA

About ADMA BIOLOGICS, INC.


  • Ticker ADMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 196,356,992
  • Market Cap $3.06B
  • Description
  • ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...
More about ADMA
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.